CLINICAL_TRIALS
trial_result
· 2017-05-17
Clinical Trial Update: Pilot Study of Using Copeptin to Predict Response to Tolvaptan [Phase 4]
Summary
A Phase 4 pilot study evaluated copeptin as a predictor of response to tolvaptan in heart failure. Results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of North Carolina, Chapel Hill | Conditions: Cardiovascular Diseases, Heart Diseases | Phase 4 | Status: COMPLETED | Results posted: 2017-05-17